ZOETIS INC. CL.A DL -,01 (ZOE.DE) Financials
ZOE.DE Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| 2023-12-31 | 14.3 billion | 9.3 billion |
| 2023-09-30 | 14.1 billion | 9.0 billion |
| 2023-06-30 | 13.7 billion | 9.1 billion |
| 2023-03-31 | 13.8 billion | 9.3 billion |
ZOE.DE Free Cash Flow and Stock based compensation
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| 2023-12-31 | 699.0 million | 17.0 million |
| 2023-09-30 | 579.0 million | 17.0 million |
| 2023-06-30 | 17.0 million | 17.0 million |
| 2023-03-31 | 326.0 million | 9.0 million |
ZOE.DE Net Income
| Date | Net Income |
|---|---|
| 2023-12-31 | 523.0 million |
| 2023-09-30 | 596.0 million |
| 2023-06-30 | 670.0 million |
| 2023-03-31 | 551.0 million |
ZOE.DE Cash and Debt
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| 2023-12-31 | 2.0 billion | - | 188.0 million |
| 2023-09-30 | 1.8 billion | - | 191.0 million |
| 2023-06-30 | 1.7 billion | - | 188.0 million |
| 2023-03-31 | 2.1 billion | - | 180.0 million |
ZOE.DE Shares Outstanding
ZOE.DE Expenses
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| 2023-12-31 | 198.0 million | 174.0 million | 565.0 million | - |
| 2023-09-30 | 145.0 million | 152.0 million | 525.0 million | - |
| 2023-06-30 | 166.0 million | 146.0 million | 556.0 million | - |
| 2023-03-31 | 223.0 million | 142.0 million | 505.0 million | - |
ZOE.DE Cost of Revenue
| Date | Revenue | Cost of Revenue |
|---|---|---|
| 2023-12-31 | 2.2 billion | 728.0 million |
| 2023-09-30 | 2.2 billion | 638.0 million |
| 2023-06-30 | 2.2 billion | 607.0 million |
| 2023-03-31 | 2.0 billion | 588.0 million |
ZOE.DE
Price: €160.90
Dividend Yield: 0.01%
Forward Dividend Yield: 1.04%
Payout Ratio: 34.09%
Dividend Per Share: 1.63 EUR
Earnings Per Share: 4.77 EUR
P/E Ratio: 37.09
Exchange: GER
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Market Capitalization: 65.8 billion
Average Dividend Frequency: 4
Years Paying Dividends: 5
DGR3: 4.67%